Mitsuo Sawai

Chief Executive Officer at SAWAI GROUP HOLDINGS CO., LTD.

Net worth: 42 M $ as of 2024-03-30

67 year

Health Technology

Profile

Mitsuo Sawai is currently the Chairman & Group Chief Executive Officer at SAWAI GROUP HOLDINGS Co., Ltd.
He also holds the position of Chairman at Sawai Pharmaceutical Co., Ltd.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SAWAI GROUP HOLDINGS CO., LTD. 2.41%	2023-09-29	1,057,000 ( 2.41% )	42 M $	2024-03-30

Mitsuo Sawai active positions

Companies	Position	Start
SAWAI GROUP HOLDINGS CO., LTD.	Chief Executive Officer	2021-03-31
Sawai Pharmaceutical Co., Ltd. Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.	Chairman	2020-06-22

All active positions of Mitsuo Sawai

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mitsuo Sawai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SAWAI GROUP HOLDINGS CO., LTD.	Health Technology

Private companies	1
Sawai Pharmaceutical Co., Ltd. Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.	Health Technology